← Back to Search

Insulin

INS068 injection for Type 2 Diabetes

Phase 2
Waitlist Available
Research Sponsored by Jiangsu HengRui Medicine Co., Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Informed consent obtained before any trial-related activities. (Trial-related activities are any procedure that will not have been performed during normal management of the subject.)
Age is 18-75 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0 to week 16+14 days follow-up
Awards & highlights

Study Summary

This study is evaluating whether a new drug can help people with type 2 diabetes.

Eligible Conditions
  • Type 2 Diabetes

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0 to week 16+14 days follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0 to week 16+14 days follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HbA1c
Secondary outcome measures
9-point SMPG profiles
Anti-drug Antibodies: Anti-INS068 Antibodies
Change in FPG
+10 more

Side effects data

From 2016 Phase 4 trial • 85 Patients • NCT01970241
21%
Hypoglycemia
100%
80%
60%
40%
20%
0%
Study treatment Arm
NPH With Corticosteroid
Control

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: INS068Experimental Treatment1 Intervention
Intervention: Drug: INS068 injection
Group II: IDegActive Control1 Intervention
Intervention: Drug: insulin Degludec
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
INS068 injection
2021
Completed Phase 2
~210

Find a Location

Who is running the clinical trial?

Jiangsu HengRui Medicine Co., Ltd.Lead Sponsor
621 Previous Clinical Trials
94,499 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~44 spots leftby Mar 2025